SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-045671
Filing Date
2023-02-23
Accepted
2023-02-23 08:02:03
Documents
15
Period of Report
2023-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d449135d8k.htm   iXBRL 8-K 26055
2 EX-99.1 d449135dex991.htm EX-99.1 62418
6 GRAPHIC g449135g0221040256658.jpg GRAPHIC 3385
7 GRAPHIC g449135g0221040757697.jpg GRAPHIC 3385
  Complete submission text file 0001193125-23-045671.txt   235901

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20230223.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20230223_lab.xml EX-101.LAB 18757
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20230223_pre.xml EX-101.PRE 11724
9 EXTRACTED XBRL INSTANCE DOCUMENT d449135d8k_htm.xml XML 3503
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 23656006
SIC: 2834 Pharmaceutical Preparations